Delivery Order SPE2DR25D2014-SPE2DR26FZ92Y
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $32,115.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Leuprolide 2-week 14 mg/2.8 ml kits, with performance completion scheduled for September 4, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a $2,908.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 ml kits. The contract, which is scheduled for ultimate completion on July 24, 2025, represents a non-set-aside competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $34,905.96 to AmerisourceBergen Drug Corp for the supply of Leuprolide 2-week 14 mg/2.8 ml kits, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 mL kits valued at $17,974.79 with a firm fixed price structure. The contract is non-competitive with no set-aside designation and is scheduled for completion by September 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with Defense Logistics...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 mL kits with a firm fixed price ceiling value of $39,070.90. This is a non-set-aside, competitively awarded delivery order to be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $4,243.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Leuprolide 2-week 14 mg/2.8 ml kits, with an ultimate completion date of September 18, 2025. This non-set-aside contract, awarded on September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- This is a $24,928.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of 4,564,639,914 units of leuprolide 2-week 14 mg/2.8 ml kits to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
- The Defense Logistics Agency Troop Support Medical awarded a $485,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561830844 LEUPROLIDE 2WK 14 MG/2.8 ML KITS. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 16, 2023 through August 17, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Leuprolide 2WK 14 MG/2.8 ML kits, a specialty medication. The contract has a ceiling value of $3,923.83 and an ultimate completion date of October 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ92YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,758.82 to AmerisourceBergen Drug Corp for Leuprolide 2-week 14 mg/2.8 ml kits on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in Conshohocken, PA 19428. Leuprolide is a hormone therapy medication commonly used in military and federal healthcare systems for treating hormone-responsive conditions. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through competitive bidding and serves as part of DLA's broader pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/9/25 |